The Difluoroboranyl-Fluoroquinolone Derivative “7a” Inhibits Bacterial DNA Gyrase and Exhibits Potent Activity Against Ciprofloxacin-Resistant S. aureus In Vitro and In Vivo Using an Acute Pneumonia Model
Molecules · 2026
DOI: 10.3390/molecules31061044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Luis Angel Veyna-Hurtado und 7 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, San Luis Potosí 78210, Mexico. Hauptthemen laut MEDLINE: Staphylococcus aureus, Fluoroquinolones, Ciprofloxacin, DNA Gyrase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
According to the World Health Organization, antibiotic research remains insufficient, emphasizing the urgent need for new active molecules, particularly against resistant bacteria. Based on known antibacterial scaffolds, new fluoroquinolone derivatives have been synthesized by our research group, including compound 7a, a difluoroboranyl-fluoroquinolone that previously demonstrated activity against sensitive strains.
Methods
The minimum inhibitory (MIC) and bactericidal (MBC) concentrations of compound 7a were determined against Staphylococcus aureus, Klebsiella pneumoniae, and Escherichia coli. The selective development of ciprofloxacin-resistant S. aureus was induced by reseeding the isolate on seven consecutive days with an antibiotic concentration that was not capable of inhibiting its development. Pharmacokinetic and toxicological properties were predicted using SwissADME, Way2Drug, and molecular docking (AutoDock Vina). In vivo toxicity was evaluated in BALB/c mice through histopathological liver and kidney analysis and serum biochemical markers. The antibacterial efficacy of 7a (80 mg/kg/day) was assessed in a murine pneumonia model induced by ciprofloxacin-resistant S. aureus. DNA gyrase inhibition was confirmed through plasmid electrophoresis assays in E. coli DH5-α cells.
Results
Compound 7a exhibited both MIC and MBC values of 0.25 μg/mL, while ciprofloxacin-resistant S. aureus strains did not exhibit a detectable MIC within the concentration range tested (up to 1024 μg/mL). In silico predictions revealed favorable ADME profiles, low toxicity, and strong interaction with DNA gyrase. In vivo, 7a showed no signs of hepatotoxicity or nephrotoxicity and effectively reduced pneumonic tissue to 1.99% in infected mice. Electrophoretic assays confirmed DNA gyrase inhibition consistent with the mechanism of fluoroquinolones.
Conclusions
Compound 7a evidenced activity against ciprofloxacin-resistant S. aureus in vitro and reduced infection progression in vivo. It also displays favorable drug-like properties, low predicted toxicity, and DNA gyrase inhibition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, San Luis Potosí 78210, Mexico.
- Laboratorio de Investigación en Síntesis Orgánica y Modificación Química, Unidad Académica de Ciencias Químicas, Universidad Autónoma de Zacatecas, Zacatecas 98160, Mexico.
- Laboratorio de Análisis Clínicos, Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, San Luis Potosí 78100, Mexico.
- Laboratorio de Patología Molecular, Departamento de Química, Universidad Autónoma de Aguascalientes, Aguascalientes 20100, Mexico.
- Departamento de Patología, Instituto Mexicano del Seguro Social (IMSS), Zacatecas 99000, Mexico.
- Laboratorio de Investigación en Terapéutica Experimental, Unidad Académica de Ciencias Químicas, Universidad Autónoma de Zacatecas, Zacatecas 98160, Mexico.
ORCID-Profile: Luis Angel Veyna-Hurtado, Hiram Hernández-López, Denisse de Loera, Martín Muñoz-Ortega, Alberto Rafael Cervantes-Villagrana
Zitieren
APA
Veyna-Hurtado, L. A., Hernández-López, H., de Loera, D., Vargas-Morales, J. M., Muñoz-Ortega, M., Troncoso-Vázquez, L., Bocanegra-Zapata, A., & Cervantes-Villagrana, A. R. (2026). The Difluoroboranyl-Fluoroquinolone Derivative “7a” Inhibits Bacterial DNA Gyrase and Exhibits Potent Activity Against Ciprofloxacin-Resistant S. aureus In Vitro and In Vivo Using an Acute Pneumonia Model. Molecules. https://doi.org/10.3390/molecules31061044
Vancouver
Veyna-Hurtado LA, Hernández-López H, de Loera D, Vargas-Morales JM, Muñoz-Ortega M, Troncoso-Vázquez L, et al. The Difluoroboranyl-Fluoroquinolone Derivative “7a” Inhibits Bacterial DNA Gyrase and Exhibits Potent Activity Against Ciprofloxacin-Resistant S. aureus In Vitro and In Vivo Using an Acute Pneumonia Model. Molecules. 2026. doi:10.3390/molecules31061044
BibTeX
@article{VeynaHurtado2026,
author = {Veyna-Hurtado, Luis Angel and Hernández-López, Hiram and de Loera, Denisse and Vargas-Morales, Juan Manuel and Muñoz-Ortega, Martín and Troncoso-Vázquez, Lorena and Bocanegra-Zapata, Alondra and Cervantes-Villagrana, Alberto Rafael},
title = {The Difluoroboranyl-Fluoroquinolone Derivative “7a” Inhibits Bacterial DNA Gyrase and Exhibits Potent Activity Against Ciprofloxacin-Resistant S. aureus In Vitro and In Vivo Using an Acute Pneumonia Model},
journal = {Molecules},
year = {2026},
doi = {10.3390/molecules31061044}
}
EUVIMED